Global Crohn’s Disease Market has been evaluated as growing market and expected that the market will reach high growth figures in the Coming Future. Crohn’s disease is a type of inflammatory bowel disease (IBD), caused by a combination of environmental, immune and bacterial factors in genetically prone individuals. There are no Medications, Drugs or Surgical Procedures that can cure or prevent Crohn’s Disease. It is expected that the disease affects about 3.2 per 1,000 people in Europe and North America. It is less common in Asia and Africa. Rates have, however, been growing, particularly in the developing world, since last few years.
The Crohn’s & Colitis Foundation of America (CCFA) stated, that over 1 Million Americans were diagnosed with Crohn’s & ulcerative colitis disorders and diseases, with maximum of them aged above 30. Increasing occurrence of Crohn’s disease has triggered a vigorous demand for its therapeutics. A survey conducted by the US Center for Disease Control (CDC) has discovered that the incidence rate of Crohn’s disease in the country is 3.1 to 14.6 new cases per 100,000 population annually. The disease is highly predominant in developed countries, especially in individuals who smoke and consume alcohol.
Request a Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/2344
Major Key Players in Crohn’s Disease Market are:
- Takeda Pharmaceutical Company Limited,
- Allergan, Inc.,
- AbbVie Inc.,
- Bayer AG,
- UCB S.A.,
- Perrigo Company plc,
- Pfizer Inc., J
- ohnson & Johnson Services, Inc.,
- Ferring B.V.
Global Crohn’s Disease Market:
Major factors leading to the growth of the market includes higher preference for Symptomatic Therapeutic, better treatment of inflammatory bowel diseases, arrival of enhanced drugs and healthier investments in R&D programs. High cost of treatment and lack of early diagnosis techniques are the major factor restricting the market growth.
North America is expected to account for the largest share of the Global Crohn’s Disease Marketin 2016, followed by Europe, the region will continue to lead the pack during the forecast period. The emerging markets of China and India will also play a key role in driving growth in the long term, primarily due to the anticipated strong uptake of Remicade over the forecast period.
Access Report Details @ https://www.marketresearchfuture.com/reports/crohns-disease-market-2344
- To provide detail Analysis of the market structure along with estimated future growth forecast for the next 5 years about various segments and sub-segments of the Global Crohn’s Disease Market.
- To provide insights about factors affecting the market growth.
- To analyze the Global Crohn’s Disease Market based on various analysis such as price analysis, supply chain analysis, Porters Five Force analysis etc.
- To provide past and estimated future revenue of the market’s segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific along with Middle East & Africa.
- To provide country level analysis of the market with respect to the current market size and future growth prospect.
- To provide country level analysis of the market’s segments which includes by procedures and by drug type.
Access the market data and market information presented through more than 25 market data tables and 25 figures spread over 85 numbers of pages of the project report “Global Crohn’s Disease Market – Forecast to 2022”
Global Crohn’s Disease Market is segmented on the basis of procedures and drug type. Based on procedures, the market is segmented into Colonoscopy, flexible Sigmoidoscopy, Computerized Tomography (CT), Magnetic Resonance Imaging (MRI), Capsule Endoscopy, Double-Balloon Endoscopy and Small Bowel Imaging. Colonoscopy due to high efficiency and accuracy is expected to command the largest market share during the forecasted period. Further on the basis of drug type the market is classified into Antibiotics, Anti-Diarrheal, Immune System Suppressors, Pain Relievers, and Anti-Inflammatory Drugs. Antibiotics are expected to command the largest market share while anti-inflammatory drugs are expected to grow at the highest CAGR during the forecasted period.
List of Tables
TABLE 1 Global Crohn’s Disease Market, By Procedure, 2013-2022 (USD MILLION)
TABLE 2 Global Crohn’s Disease Market, By Drug Type, 2013-2022 (USD MILLION)
TABLE 3 Global Crohn’s Disease Market By Region 2013-2022 (USD MILLION)
List of Figures
FIGURE 1 Research Process
FIGURE 2 Porters Five Forces Model
FIGURE 3 Global Crohn’s Disease Market, By Procedure
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Company Name: Market Research Future
Contact Person: Akash Anand
Phone: +1 646 845 9312
Address:Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India